Cite
HARVARD Citation
Prager, F. et al. (2009). Intravitreal bevacizumab (Avastin®) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial. British journal of ophthalmology. 93 (4), pp. 452-456. [Online].